Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Methylnaltrexone for Neostigmine-Resistant Ogilvie Syndrome

Tahir, Muhammad MD1; Singh, Amanapal MD2; Amjad, Waseem MD3

doi: 10.1097/MJT.0000000000000743
Letters to the Editor

1Department of Internal Medicine, University at Buffalo, Buffalo, NY

2Department of Gastroenterology, Roswell Park Cancer Institute, Buffalo, NY

3Department of Internal Medicine, Northwell long Island Jewish Foresh Hills Hospital, Forest hills, NY

The authors have no conflicts of interest to declare.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.